Neuberger Berman Group LLC Cytosorbents Corp Transaction History

Neuberger Berman Group LLC

  • $121 Billion
  • Q4 2024

A detailed history of Neuberger Berman Group LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,681,883 shares of CTSO stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,681,883
Previous 1,781,360 5.58%
Holding current value
$1.93 Million
Previous $2.67 Million 43.38%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$0.74 - $1.35 $73,612 - $134,293
-99,477 Reduced 5.58%
1,681,883 $1.51 Million
Q3 2024

Nov 14, 2024
BUY
$0.7 - $1.55 $171,392 - $379,511
244,846 Added 15.94%
1,781,360 $2.67 Million
Q2 2024

Nov 14, 2024
SELL
$0.7 - $1.01 $263,236 - $379,812
-376,052 Reduced 19.66%
1,536,514 $1.08 Million
Q2 2024

Aug 13, 2024
SELL
$0.7 - $1.01 $263,236 - $379,812
-376,052 Reduced 19.66%
1,536,514 $1.08 Million
Q1 2024

Nov 14, 2024
BUY
$0.86 - $1.07 $95,259 - $118,520
110,767 Added 6.15%
1,912,566 $1.82 Million
Q1 2024

May 13, 2024
BUY
$0.86 - $1.07 $1.64 Million - $2.05 Million
1,912,566 New
1,912,566 $1.82 Million
Q4 2023

Nov 14, 2024
BUY
$1.08 - $1.94 $286,507 - $514,652
265,285 Added 17.27%
1,801,799 $2 Million
Q4 2023

Feb 09, 2024
BUY
$1.08 - $1.94 $323,031 - $580,259
299,103 Added 19.9%
1,801,799 $2 Million
Q3 2023

Nov 14, 2023
BUY
$1.86 - $4.03 $26,134 - $56,625
14,051 Added 0.94%
1,502,696 $2.83 Million
Q2 2023

Aug 11, 2023
SELL
$2.37 - $3.65 $140,488 - $216,364
-59,278 Reduced 3.83%
1,488,645 $5.34 Million
Q1 2023

May 12, 2023
BUY
$1.79 - $4.17 $33,702 - $78,512
18,828 Added 1.23%
1,547,923 $5.22 Million
Q4 2022

Feb 13, 2023
BUY
$1.03 - $2.03 $51,010 - $100,535
49,525 Added 3.35%
1,529,095 $2.37 Million
Q3 2022

Nov 15, 2022
BUY
$1.2 - $2.46 $181,560 - $372,198
151,300 Added 11.39%
1,479,570 $2 Million
Q2 2022

Aug 15, 2022
BUY
$1.76 - $3.22 $134,566 - $246,194
76,458 Added 6.11%
1,328,270 $2.92 Million
Q1 2022

May 13, 2022
SELL
$2.88 - $4.23 $12,257 - $18,002
-4,256 Reduced 0.34%
1,251,812 $3.98 Million
Q4 2021

Feb 11, 2022
SELL
$4.05 - $8.11 $18,249 - $36,543
-4,506 Reduced 0.36%
1,256,068 $5.26 Million
Q3 2021

Nov 12, 2021
BUY
$7.0 - $9.71 $2.89 Million - $4.01 Million
413,485 Added 48.81%
1,260,574 $10.2 Million
Q2 2021

Aug 13, 2021
SELL
$7.55 - $9.42 $126,273 - $157,549
-16,725 Reduced 1.94%
847,089 $6.39 Million
Q1 2021

May 13, 2021
SELL
$8.23 - $11.48 $406,027 - $566,365
-49,335 Reduced 5.4%
863,814 $7.47 Million
Q4 2020

Feb 10, 2021
BUY
$7.65 - $8.98 $2.53 Million - $2.97 Million
330,555 Added 56.74%
913,149 $7.27 Million
Q3 2020

Nov 12, 2020
BUY
$7.37 - $11.54 $4.29 Million - $6.72 Million
582,594 New
582,594 $4.64 Million

Others Institutions Holding CTSO

# of Institutions
58
Shares Held
15.7M
Call Options Held
16K
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $50.1M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email